Mark Davis
Mark is a technically trained business services professional whose CMC expertise includes full responsibility for transactions involving a combination of IP, development, and supply elements. Supporting cell therapy business deals with 3 of the top 15 pharmaceutical companies worldwide, he negotiated various agreements that often required "green field" development of technologies specific to a program. In addition, Mark has a successful track record of significant risk and cost reductions in global scale supply chain development, including small molecules of leading pharmaceutical companies.
Oliver Zanon
Oliver is an experienced legal counsel, mediator and business engineer. He started his career at Lonza and in 2005, founded his own law office focusing on legal support for big and small pharmaceutical companies - including Novartis, Actelion and Polyphor - in procurement and clinical studies. At Novartis, he served both on the sponsor/CRO side and on the side of hospitals and clinics. Based on this broad legal perspective, Oliver will create the best possible legal frame around your procurement needs.
Christoph Becker
Starting out as PhD biochemist, Christoph’s 25-year track record in the pharmaceutical, CMO and chemical industry includes global companies such as Novartis, Lonza and Siegfried as well as consulting work with biotech start-ups. Christoph's main areas of expertise are custom-made APIs & intermediates (chemical and biologics), lean manufacturing, and building partnerships with providers of complex drug conjugates. An additional focus is the consulting service NegotiumBio offers to clients who want to expand into new therapeutic areas as an investment opportunity.
Elena Rodal Salgueiro
With a BSc in Biology and a Master’s degree in Laboratory Management, Elena has developed her professional career of 12+ years in clinical, environmental and pharmaceutical quality laboratories. During her career, she has designed and implemented the ISO 17025 standard, being responsible for the procurement and management of laboratory equipment, chemicals and consumables. She has also managed the GMP library of manufacturing standards and supplier qualification.
Carlos Sousa
A strategic sourcing and supply chain executive with degrees in biotechnology and microbiology, Carlos brings more than 20 years of experience in the biotech and pharma industry to the table. He joined NegotiumBio from FAMAR in Madrid, where as Purchasing and Supply Chain Senior Group Director, he managed a team of 19 people, covering Customer Service, Supply Chain Planning, and Purchasing (spend of 140 Mio €). Previous to that, he held senior roles in category management for R&D equipment and biological intermediates at Novartis and Lonza in Switzerland. Carlos has exceptionally broad expertise in Strategic Sourcing, Supply Chain and Procurement processes definition, as well as cGMP and ISO Quality frameworks and HSE Regulations. His proven track record in leading multi-disciplinary teams reflects on his special interest and talent in coaching and mentoring.
Moranda Marcinek
With a BA in Strategic Communications, Moranda is an operationally trained professional whose expertise is in procurement, contract administration, accounts payable support, and facilities management. She has a successful track record of vendor relationship management and meeting customer goals. She is responsible for supporting business operations within NegotiumBio, as well as external market research for our clients.
Andreas Biland
A PhD in organic chemistry, Andreas’ track record includes 18 years of executive leadership positions in R&D and business in the global chemical industry (SI Group, Corden Pharma). He has comprehensive expertise in the development, characterization and upscaling of chemical products and small molecule APIs as well as change and innovation management.
In addition, Andreas designed and took ownership of several innovation business processes. He also facilitated new networks and partnerships by connecting industrial R&D teams with universities, research institutions and other service partners.